- Home
- KLTOW vs KALA Comparison
KLTOW vs KALA Comparison
Compare KLTOW & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- KALA
- Stock Information
- Founded
- KLTOW N/A
- KALA 2009
- Country
- KLTOW United States
- KALA United States
- Employees
- KLTOW 3
- KALA N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- KLTOW Health Care
- KALA Health Care
- Exchange
- KLTOW Nasdaq
- KALA Nasdaq
- Market Cap
- KLTOW N/A
- KALA N/A
- IPO Year
- KLTOW 2022
- KALA 2017
- Fundamental
- Price
- KLTOW $0.02
- KALA $3.42
- Analyst Decision
- KLTOW
- KALA Strong Buy
- Analyst Count
- KLTOW 0
- KALA 2
- Target Price
- KLTOW N/A
- KALA $15.00
- AVG Volume (30 Days)
- KLTOW N/A
- KALA 95.4K
- Earning Date
- KLTOW N/A
- KALA 05-20-2025
- Dividend Yield
- KLTOW N/A
- KALA N/A
- EPS Growth
- KLTOW N/A
- KALA N/A
- EPS
- KLTOW N/A
- KALA N/A
- Revenue
- KLTOW N/A
- KALA N/A
- Revenue This Year
- KLTOW N/A
- KALA N/A
- Revenue Next Year
- KLTOW N/A
- KALA N/A
- P/E Ratio
- KLTOW N/A
- KALA N/A
- Revenue Growth
- KLTOW N/A
- KALA N/A
- 52 Week Low
- KLTOW N/A
- KALA $2.92
- 52 Week High
- KLTOW N/A
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- KALA 38.16
- Support Level
- KLTOW N/A
- KALA $3.15
- Resistance Level
- KLTOW N/A
- KALA $5.03
- Average True Range (ATR)
- KLTOW 0.00
- KALA 0.46
- MACD
- KLTOW 0.00
- KALA 0.11
- Stochastic Oscillator
- KLTOW 0.00
- KALA 23.70
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.